MedTrace Logo

International Prospective Observational Cohort Study for Optimal Bowel Resection Extent and Central Radicality for Colon Cancer

NCT02938481 · Status: COMPLETED · Type: OBSERVATIONAL · Enrollment: 3647

Last updated 2026-01-29

No results posted yet for this study

Summary

The T-REX study aims to clarify the actual status of metastatic lymph node (LN) distribution in colon cancer and provide reliable evidence regarding the optimal length of bowel resection and the extent of central lymph node dissection in colon cancer surgery.

Conditions

Sponsors & Collaborators

  • Tokyo Medical and Dental University, Japan

    collaborator UNKNOWN

  • Translational Research Center for Medical Innovation, Kobe, Hyogo, Japan

    lead OTHER

Principal Investigators

  • Kenichi Sugihara, M.D., Ph.D · Tokyo Medical and Dental University, Japan

Eligibility

Sex
ALL
Healthy Volunteers
No

Timeline & Regulatory

Start
2013-05-30
Primary Completion
2023-12-31
Completion
2025-01-31

Countries

  • Germany
  • Japan
  • Lithuania
  • Russia
  • South Korea
  • Taiwan
  • United Kingdom

Study Locations

More Related Trials

Entities

Diseases

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT02938481 on ClinicalTrials.gov